glp-1 news today october 9 2025 Beyond GLP-1: the next wave of weight-loss medication innovation Designing GLP-1 delivery: structural perspectives

When the last injection clears, circulating GLP-1 receptor agonist activity drops to zero, and the central nervous system reverts to its pre-drug set-point within two to four weeks

Increased dietary intake, decreased leptin level, and high affinity to histamine (H1) receptors [158], especially by TCAs such as imipramine-type antidepressants, may be responsible for the underlying mechanisms

Proper PT-141 dosing protocols vary between delivery methods, with nasal formulations often requiring slightly higher doses to match injectable potency

N.LoganathanG.AhmadA.HeringB

You can read the full article at The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity A study investigated the effects of once-weekly subcutaneous (s.c.) semaglutide 2.4 mg on gastric emptying, appetite, and energy intake in people with obesity

GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after eating that signals fullness to the brain